Treatment of human brucellosis

Journal Medical Libanais

Volumn 48, Issue 4, 2000, Pages 255-263

  Solera, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BRUCELLOSIS; DISEASE ASSOCIATION; HUMAN; RELAPSE; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION;

ACUTE DISEASE; AGE FACTORS; BRUCELLOSIS; CHILD; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PATIENT SELECTION; PREGNANCY; PROGNOSIS; RECURRENCE; RIFAMPIN; STREPTOMYCIN; TREATMENT OUTCOME;

EID: 0034495538     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Complications associated with Brucella melitensis infection : A study of 530 cases
2. Modern chemotherapy for brucellosis in humans
3. Treatment of human brucellosis with azithromycin and gentamicin
4. Recognition and optimum treatment of brucellosis
5. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis
6. Tetracyclines
7. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin
8. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs
9. Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis
10. A comparative study of therapeutic agents used for treatment of acute brucellosis
11. Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy
12. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis
13. Baltimore : Williams & Wilkins
14. Sensitivity of 115 strains of the genus Brucella to some antibiotics (cephalosporins, ureidopenicillins and aminoglycosides)
15. Sensibilidad antimicrobiana in vitro de cepas de Brucella melitensis aisladas en una área endémica (Lima, Perú
16. A multicenter therapeutic study of 1100 children with brucellosis
17. Failure of short antimicrobial treatments for human brucellosis
18. Treatment of Human Brucellosis with doxycycline and gentamicin
19. Treatment of human brucellosis with and doxycycline
20. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides
21. Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin
22. Protective effect of liposomal gentamicin against systemic acute murine brucellosis
23. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections
24. Rifamycins
25. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis
26. Tratamiento de la brucelosis con rifampicina
27. Traitement de la brucellose par la rifampicine. Résultats préliminaires
28. Brucellosis treated with rifampin
29. Rifampin resistance in a strain of Brucella melitensis after treatment with doxycycline and rifampin
30. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A meta-analysis of randomized controlled trials
31. The sensitivity of Brucella abortus to chemotherapeutic agents
32. Susceptibility of Brucella strains to antibiotics
33. Increasing resistance of Brucellae to Co-Trimoxazole
34. Trimethoprim-sulphametoxazole in acute brucellosis
35. Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis
36. Treatment of childhood brucellosis : Results of a prospective trial on 113 children
37. In vitro activities of six new fluoroquinolones against Brucella melitensis
38. Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones
39. Lack of effective bactericidal activity of new quinolones against Brucella sp.
40. The biogenesis of lysosomes
41. Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis
42. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections
43. Development of ciprofloxacin resistance in Brucella melitensis
44. Brucella endocarditis on Starr aortic valve prosthesis
45. Quinolones in treatment of human brucellosis : Comparative trial of ofloxacin-rifampin versus doxycycline-rifampin
46. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis
47. In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis
48. In vitro activities of new macrolides and rifapentine against Brucella spp.
49. Antibacterial activity of azithromycin against Brucella melitensis
50. Phagocyte uptake and transport of azithromycin
51. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks and streptomycin for 2 weeks
52. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis
53. Comparison of three different regimens in the treatment of acute brucellosis : A multicenter multinational study
54. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis
55. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study
56. Ensayo terapeutico comparativo y multicentrico de rifampicina y doxiciclina frente a estreptomicina y doxiciclina en la brucelosis humana
57. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis
58. Brucellar osteomyelitis involving prosthetic extra-articular hardware
59. Brucella spondylitis : Review of 35 cases and literature survey
60. Hepatosplenic abscesses due to Brucella melitensis : Report of a case involving a child and review of the literature
61. Active splenic granuloma as a source of recurrent brucellosis. Successful surgical treatment
62. Brucellosis. Indications for splenectomy
63. Infective endocarditis and occult splenic abscess caused by Brucella melitensis infection : A case report and review of the literature
64. Brucella bacteraemia : Clinical and laboratory observations in 160 patients
65. Zoonotic Endocarditis
66. Brucella endocarditis : The role of combined medical and surgical treatment
67. Surgical treatment of Brucella endocarditis
68. Brucella endocarditis. Report of one case and review of the literature
69. Brucella endocarditis of the aortic valve
70. Brucella infective endocarditis. Successful combined medical and surgical therapy
71. The role of aggressive medical therapy along with early surgical intervention in the cure of Brucella endocarditis
72. Management of brucella endocarditis of a prosthetic valve
73. Human brucellosis in Kuwait : A prospective study of 400 cases
74. Clinical categories of neurobrucellosis. A report on 19 cases
75. Brucella meningitis : Presentation, diagnosis and treatment - A prospective study of ten cases
76. Neurobrucellosis : Clinical and therapeutic features
77. Brucellar meningitis
78. Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis
79. Central nervous system brucellosis : Presentation, diagnosis and treatment
80. An adolescent Pakistani girl with chronic meningitis
81. Posttreatment follow-up of brucellosis by PCR assay
82. Characteristics of and risk factors for relapse of brucellosis in humans
83. Multivariate model for predicting relapse in human brucellosis
84. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis
85. Brucellar arthritis in children and its successful treatment with trimethoprim-sulphamethoxazole (cotrimoxazole)
86. Obstetric and gynecologic implication of brucellosis in Kuwait
87. Pregnancy and brucellosis
88. Brucelosis durante el embarazo : Evolución y resultados perinatales
89. Brucella